AskNiveshClosed·17:39 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs
  • Earnings

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Currency Rates
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to SUNPHARMA

Sun Pharmaceutical Industries Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsSep-24Dec-24Mar-25Jun-25Sep-25Dec-25Mar-26Jun-26
Revenue
13,29113,67512,95913,85114,47815,52114,61215,300
Other income
354466613464470579458724
Expenses
10,04810,3499,95610,32510,78111,38311,51911,721
Cost of materials consumed
1,6391,4081,8451,7721,6221,8132,1822,026
Purchases of stock-in-trade
8751,2391,0371,0481,0889227531,020
Change in inventories
18094-245-5273209-135-83
Employee benefit expense
2,4782,5522,4892,8022,7652,8922,9603,227
Finance costs
695249751007886100
Depreciation & amortisation
626631664701730732775739
Other expenses
4,1814,3744,1173,9334,2044,7354,8964,692
EBITDA
4,2934,1593,9673,9494,9985,0374,4124,938
EBIT
3,6673,5283,3033,2484,2684,3053,6374,199
Exceptional items
--316-362-818--489--204
Profit Before Tax
3,5983,4763,2543,1734,1684,2273,5514,099
Tax expense
5675591,0948701,0318268281,188
Net Profit
3,0372,9132,1542,2933,1253,3812,7102,901
Financial Ratios
Operating Profit Margin
27.59%25.80%25.49%23.45%29.48%27.74%24.89%27.44%
EBITDA Margin
32.30%30.41%30.61%28.51%34.52%32.46%30.19%32.27%
Net Profit Margin
22.85%21.30%16.62%16.55%21.58%21.78%18.55%18.96%
Earnings Per Share (₹)
12.7012.109.009.5013.0014.0011.3012.10

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.